Evaluation of Platanus orientalis L. distillate effects on allergic rhinitis
Early Phase 1
Recruiting
- Conditions
- Allergic rhinitis.Allergic rhinitis, unspecified
- Registration Number
- IRCT20100218003361N2
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Patients aged 18-65 years
Obtaining the informed consent
Fulfillment of allergic rhinitis diagnostic criteria and the history of allergic rhinitis for at least two consecutive years
Exclusion Criteria
Systemic corticosteroid therapy in the past three months
Local corticosteroid therapy in the past fifteen days
Pregnancy
Breast feeding
Females at age of fertility with no particular pregnancy prevention method
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Allergic rhinitis symptom score (nose, eyes, respiratory). Timepoint: Daily. Method of measurement: Filling the daily symptom questionnaire and symptom scores by the patient.;Comparing the daily mean scores of allergic rhinitis. Timepoint: Day 1- Day 30. Method of measurement: Statistical analyses.;Quality of life score (regular activities, recreational activities, sleep). Timepoint: At enrollment, at days 14 and 30. Method of measurement: Quality of life scoring in quality of life questionnaire.;Observing the variations in the severity of allergic rhinitis symptoms. Timepoint: Day 30. Method of measurement: Clinician evaluations.
- Secondary Outcome Measures
Name Time Method